Is Marsden working 'at haste'? I would hate to see what he is like when working slowly. Let's make it clear...the longer he can spin out this play then the more time getting the salary and achieving nothing. What's not to like?
It would seem that the present ceo didn't have much of a grip on the financials as he was spending money freely and talking up the company prospects. CPX might be better off with Dr C in charge who has a proven track record. He would max out his money by getting a controlling interest and then making the company successful. At one time many thought this could become a £50-100m valuation. If Cooley and 'institutions' have 40% then that is a powerful position.
One problem going forward is that no one will now take anything said by AS at face value. It will either be not believed or people will be trying to second guess what he really means or perhaps that he is making it up as per usual. On the other hand hard clinical data cannot lie..or can it?!
I think GC buying is genuine in that he sees a future viable company. That view is in part based on his earlier 3% holding. That was not made as a punt or a bet. He has an industrial background and I think he can see a way forward. In his 10 years plus of running a plc he must know who and where potential funders are for companies like this. Let's see what unfolds here.
Nice post agree with what you say. Yes AIM is a truly rotten and corrupt market with insider dealing rife and no sanctions against it. As for what happens here its impossible to tell. What is puzzling is why the company seemingly set out to destroy the share price. I think most expected a modest fund raise of some sort linked to one off costs from AK departure and legal costs.
The problem is when the shares are mainly private retail held the company feels it can do what it pleases. When institutions are involved then its different. There are some ii's here so hopefully they can make their views known.
Our fortunes are very much linked to Lars and what he can do. I also think the Chairman and NEDs (Steen) should be able to bring something to the party. The new lady is financial controller so less senior than Mike I guess.
RE: Cytiva / bams / value infection points / LFD / licence deals3 Mar 2024 10:26
I think the hardest part to take in all this is the fact the loyal long term holders has been royally shafted and johnny come lately new holders have been 'rewarded'. I don't think anyone on these boards will ever see AS in a positive light. To talk of non-dilutive funding options prior to this rock bottom 50p raise adds insult to injury.
I agree..it has become totally discredited. It's like a gambling casino and the main players are spivs, charlatans,day traders and punters with the odd shorter thrown in who can find a borrow. MM actions not helpful either and conducive to wild swings on low volumes. As for being an incubator for long term 'investment'...no chance. I don't think I will ever touch another AIM share and certainly not an IPO. Shame as most damage self inflicted by lax regulation IMO.
Agree this company needs to improve on a number of fronts. The Docket Bird release on court costs was ambiguous and for some reason various folk decided to take a negative slant. I know of one PI who sold out completely yesterday. But it was a foreseeable issue to the company to address promptly if people there were on the ball or the advisers were doing their job properly. Anyway panic over. No reason to disagree with Cavendish position on financing.
This company has been run in a criminally incompetent manner for years. It's little more than a lifestyle play for a few people at the top. It has NEVER been self sustaining and keeps coming back for more funding to maintain the lifestyle support. This should never have been allowed to float.
Peter Shea was ceo at Daniel Stewart a broker. He appointed lots of family members to senior positions. They were utterly useless but if you got on the wrong side of one of these 'Sheas' you got fired.
Yes medical and military seem to be good markets with big potential alongside the more obvious IOT and automotive.
The Holy Grail would be mobile phones but I'm sure that would involve some joint manufacturing arrangement if it ever happened.
Can't say I'm a big fan of Trump but the award of $83m against him for defamation (hurt feelings?!) rather shows up the manifest weaknesses of the US jury system ..IMO. Let's hope a more enlightened judge can see through this nonsense.
You have some interesting thoughts here josey. I'm looking at this one for a rebound at some stage. This was once a serious company and I'm somewhat surprised at the lack of management changes given the disastrous decisions that have been made here. I think the main culprit left the company (previous ceo) before the sh** hit the fan.....paying way too much for acquisitions and loading up with debt at the wrong time.